Delivery Order SPE2DB25D7060-SPE2DB25FXSNR
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $12,759.44 and a completion date of May 22, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,179.39, is for the delivery of the prescription medication Contrave ER 8-90 mg tablet in quantities of 120 per order. The contract is a firm fixed-price, non-set-aside agreement with a completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $21,205.44 and a completion date of June 11, 2025. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Contrave ER 8-90 mg tablets. The contract has a firm fixed price of $4,154.42 and a period of performance through April 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $4,796.04 and a completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of medical commodities, including prescription...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $2,082.65 and an ultimate completion date of October 18, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a Delivery Order federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $6,398.48 and a period of performance through May 9, 2024. AmerisourceBergen maintains a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,565,243,433 tablets of the drug Contrave ER 8-90 mg, with a ceiling value of $1,199.01. The contract is a firm fixed price Delivery Order with a completion date of July 25, 2024. This contract is not designated as a set-aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,906.12, is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of July 16, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,904.99, is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has a firm fixed price and is set to expire on May 31, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...